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Background
Network Meta-Analysis (NMA)
• Combines evidence on multiple treatments from several studies
• Arranges treatments on a network structure joined by study 
evidence
• Provides a consistent set of treatment effect estimates
• Is routinely used to inform clinical guideline recommendations, 
technology appraisals
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Example: Headaches clinical guideline
Treatment
Mean change in 
headache days per 
month (95% CrI)
1 Placebo 0
2 Telmisartan -0.51 (-2.32, 1.27)
3 Amitriptyline -1.14 (-2.45, 0.16)
4 Divalproex Sodium 0.13 (-0.99, 1.23)
5 Gabapentin 0.00 (-1.60, 1.58)
6 Topiramate -1.04 (-1.52, -0.58)
7 Propranolol -1.19 (-2.20, -0.20)
8 Propranolol/Nadolol -0.60 (-1.65, 0.45)
(NICE CG151.1, 2015)
Minimal Clinically Important Difference 
(MCID) = 0.5 days per month
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Motivation
How robust are the recommendations based on NMA?
Quality
Low High
Influence
Low
High
The quality of evidence reflects the extent to which 
our confidence in an estimate of the effect is adequate to support 
a particular recommendation.  (GRADE Handbook, 2013)
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Threshold Analysis
Create an invariant interval for a data point:
Invariant Interval
+ve threshold–ve threshold
How much would the evidence have to change before 
we reach a new recommendation?
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Threshold Analysis
We can do this at two “levels”:
• Study level
• Thresholds for each individual study estimate
• Contrast level
• Thresholds for combined body of evidence on a contrast
• Highly flexible due to approximation step
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Example: Headaches clinical guideline – contrast level
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Example: Headaches clinical guideline – contrast level
Example: Headaches clinical guideline – study level
Example: Headaches clinical guideline – study level
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Example: Social Anxiety
• 41 treatments, 100 studies
• Class effect model with 17 classes
• 84 direct comparisons and many “first 
order” loops 
⇒ GRADE impractical
Based on efficacy alone recommendation is 
CBT + Phenelzine (41)
(NCC-MH, 2013)
Example: Social Anxiety – contrast level
Thresholds smaller 
than 0.8 SMD
Thresholds larger 
than 0.8 SMD
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Example: Social Anxiety
We can also use threshold analysis to investigate more specific 
concerns
• E.g. groups of treatments or studies with certain characteristics
Psychological treatment bias – could this affect the 
recommendation?
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Example: Social Anxiety – psychological treatment bias
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Conclusions
• Evidence quality and risk of bias are not sufficient to assess robustness of decisions
• Threshold analysis provides insight into the effects of changes in the evidence on 
treatment decisions
• We can have more confidence in recommendations where thresholds are large
• We can focus attention on the quality of decision-sensitive trials and contrasts
• More complex analyses can investigate specific concerns in the evidence
• Can be used with a range of decision rules or for decisions based on cost-effectiveness
Phillippo DM, Dias S, Ades AE, Didelez V and Welton NJ (2018). Sensitivity of treatment recommendations to 
bias in network meta‐analysis. J. R. Stat. Soc. A, 181: 843-867. doi:10.1111/rssa.12341
R package nmathresh package available on CRAN
G-I-N Manchester 2018 17
Thank You
This work was supported by the Centre for Clinical Practice, 
NICE, with funding to the Clinical Guidelines Technical Support 
Unit, University of Bristol.
This work was undertaken with the support of the MRC 
ConDuCT-II Hub (MR/K025643/1), and the MRC grant 
MR/M005232/1.
